In view of our study identifying a second pro-metastatic/pro-EMT gene, Twist1, as a direct target of miR-33a, it is logical to suggest that two or more genes are employed to mediate the anti-metastatic function of miR-33a in lung cancer. This evidence concerns the gene TWIST1 and lung cancer.